Skip to main content

Peer Review reports

From: A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy

Original Submission
27 Mar 2023 Submitted Original manuscript
11 Apr 2023 Reviewed Reviewer Report
3 May 2023 Reviewed Reviewer Report
14 Jul 2023 Author responded Author comments - Zude Chen
Resubmission - Version 2
14 Jul 2023 Submitted Manuscript version 2
22 Jul 2023 Reviewed Reviewer Report
18 Aug 2023 Reviewed Reviewer Report
11 Sep 2023 Author responded Author comments - Zude Chen
Resubmission - Version 3
11 Sep 2023 Submitted Manuscript version 3
15 Sep 2023 Author responded Author comments - Zude Chen
Resubmission - Version 4
15 Sep 2023 Submitted Manuscript version 4
24 Sep 2023 Author responded Author comments - Zude Chen
Resubmission - Version 5
24 Sep 2023 Submitted Manuscript version 5
Publishing
26 Sep 2023 Editorially accepted
25 Oct 2023 Article published 10.1186/s12916-023-03094-0

You can find further information about peer review here.

Back to article page